retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric What Is Retatrutide? The Triple
Description
Public interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: a Google trends analysis
In conjunction with potential copays as low as $25, Foundayo represents a cost-effective and efficient option for weight management
Additional comparative evidence comes from: A 2025 narrative review synthesising randomised and indirect comparison data across obesity and type 2 diabetes trials, confirming tirzepatides superiority on weight and HbA1c [2]
The primary caution relates to female partners
